Immix Biopharma, Inc. IMMX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s total equity?
- Immix Biopharma, Inc. (IMMX) reported total equity of $84.36M in Q1 2026.
- How has Immix Biopharma, Inc.'s total equity changed year-over-year?
- Immix Biopharma, Inc.'s total equity increased by 779.4% year-over-year, from $9.59M to $84.36M.
- What is the long-term trend for Immix Biopharma, Inc.'s total equity?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s total equity has grown at a 81.7% compound annual growth rate (CAGR), from -$4.73M to $93.8M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.